Mr. R.A. Shah – Chairman.
Mr. R.A. Shah is a leading Solicitor and a Senior Partner of M/s. Crawford Bayley
& Co., a firm of Advocates & Solicitors. He specializes in a broad spectrum
of corporate laws in general, with special focus on Foreign Investments, Joint Ventures,
Technology and License Agreement, Intellectual Property Rights, Mergers and Acquisitions,
Industrial Licensing, and Anti Trust Laws, Company Law and Taxation. He is the Chairman/Director
of various public limited companies and Chairman/member of Audit Committees.
Mr. R.A. Shah was first appointed on the Board on November 9, 1965.
Mr. Pradip P. Shah – Director
Mr. Pradip Shah holds an MBA from the Harvard Business School. He is also a Chartered
Accountant and a Cost Accountant and ranked first in India in the Chartered Accountancy
Mr. Pradip Shah is the ex-Managing Director of CRISIL, India’s first and the
largest credit rating agency. Prior to founding CRISIL, Mr. Pradip Shah assisted
in founding the Housing Development Finance Corporation (HDFC) in 1977. Mr. Shah
has also served as a consultant to USAID, the World Bank and the Asian Development
Bank. Mr. Shah is a Director on the Board of several reputed companies. He is also
a member of various prestigious committees/commissions. Mr. Pradip Shah is presently
the Chairman of Indasia Fund Advisors Pvt. Ltd.
Mr. Pradip P. Shah was appointed to the Board on December 7, 1999.
Mr. Uday Khanna – Director
Mr. Uday Khanna is a Chartered Accountant. Mr. Khanna is the Chairman of Bata India Limited. Mr. Khanna was the Managing Director & CEO of Lafarge India from July 2005 to July 2011 and subsequently the Non-Executive Chairman till 24th September, 2014.
Mr. Khanna joined the Lafarge Group in Paris on June 1, 2003 as Senior Vice President for Group Strategy, after a long experience of almost 30 years with Hindustan Lever Limited / Unilever in a variety of financial, commercial and general management roles both nationally and internationally.
Mr. Khanna’s last position before joining Lafarge, was Senior Vice President Finance, Unilever - Asia, based in Singapore.
Mr. Khanna has earlier been on the Board of Hindustan Lever Limited (Hindustan Unilever Limited) as Director - Exports.
Mr. Khanna has also worked as Vice Chairman of Lever Brothers in Nigeria and General Auditor for Unilever-North America based in the USA.
Mr. Khanna was the President of the Indo-French Chamber of Commerce & Industry in 2008 and 2009 and is currently President of the Bombay Chamber of Commerce & Industry and on the Managing Committee of the Associated Chamber of Commerce & Industry.
Mr. Khanna was appointed to the Board on May 21, 2012.
Mr. Samir Kazi – Executive Director
Mr. Samir Kazi is a lawyer with over 20 years of rich legal experience. Mr. Kazi earned his Bachelor’s of Law degree from the University of Mumbai in the year 1999.
Mr. Samir Kazi started his career with an illustrious law firm in Mumbai - Mulla & Mulla & Craigie Blunt & Caroe, where Mr. Samir Kazi practiced for over 7 years before taking up in-house law practice. Thereafter, Mr. Samir Kazi was a Legal advisor to the Hinduja Group India Limited, before being associated with Pfizer Limited since 2007.
Mr. Samir Kazi has represented various clients in a broad range of litigation disputes and transactional matters, handled complex commercial and business litigation and specialized in alternative dispute resolution. Mr. Samir Kazi’s core competencies includes Corporate Laws, Intellectual Property laws, Corporate Governance, Cross Border transactions, Mergers & Acquisitions, Joint Ventures, Amalgamations and Regulatory laws amongst various other areas of expertise.
Mr. Samir Kazi is a part of Pfizer Limited Leadership team and is responsible for providing quality legal advice, including inputs on matters relating to industrial bodies, governance, compliance and mergers & acquisitions, establishment of strategic alliances, partnerships and relationships with internal & external clients.
Mr. Samir Kazi was appointed to the Board on February 14, 2020.
Mr. S. Sridhar – Managing Director
Mr. S. Sridhar is a Chartered Accountant by profession with over 20 years of experience in the finance field. Mr. Sridhar joined Pfizer in June 2008. Mr. Sridhar has served as the Chief Financial Officer of Pfizer Limited for a period of 7 years and was appointed as the Executive Director on the Board of Directors of the Company in May 2013. He has also concurrently led the Company’s Distribution function for 3 years and is also currently leading Pfizer’s Anti-Infective, Cardio vascular, Ophthalmology business.
Before joining Pfizer, Mr. Sridhar held the position of Finance Director of Diageo India Private Limited. Mr. Sridhar was also on the Board of erstwhile Wyeth Limited.
Mr. Sridhar was appointed to the Board on May 14, 2013 as an Executive Director. He was subsequently appointed as the Managing Director of the Company effective March 18, 2016.
Mr. Sunil S. Lalbhai – Director
Mr. Sunil S. Lalbhai, holds MS degree in Chemistry from the University of Massachusetts and MS degree in Economic Policy and Planning from Northeastern University. Mr. Lalbhai has expertise and wide experience in the Management field. He is presently the Chairman and Managing Director of Atul Limited, a diversified chemical company where he has been working since 1983.
Mr. Lalbhai was also on the Board of Wyeth Limited since 2002 till its amalgamation with Pfizer Limited.
Mr. Lalbhai was appointed to the Board on February 14, 2015.
Mr. Milind Patil – Executive Director
Mr. Milind Patil is a graduate of commerce and a fellow member of the Institute of Chartered Accountants of India. Mr. Patil has also completed financial excellence program & financial leadership program and advance leadership program from Harvard Business School, USA and Tuck School of Management, USA respectively.
Mr. Milind Patil joined Pfizer Limited effective August 16, 2018 as the Chief Financial Officer. Mr. Milind Patil is a finance professional with over two decades of experience predominantly in the Pharmaceutical industry and having versatile exposure in global MNCs in challenging and complex business environments across multiple finance and business functions. He has a proven track record in business turnaround strategies and managing stakeholders, people, performance and risks and opportunities effectively. Mr. Patil’s last employment was as Chief Financial Officer for Middle East North Africa (MENA) region for Novartis based out of Dubai.
Mr. Milind Patil was awarded the “CA.CFO-healthcare sector award” by the Institute of Chartered Accountants of India in February 2015.
Mr. Milind Patil was appointed to the Board on November 14, 2018.
Ms. Meena Ganesh – Director
Ms. Meena Ganesh is a PGDM holder from IIM Calcutta and has a graduate degree in Physics from the Madras University. In 2011, she was conferred the ‘Distinguished Alumnus’ award by IIM Calcutta.
Ms. Meena Ganesh is one of India’s foremost business leaders and most successful entrepreneurs with nearly three decades of experience in industries including healthcare, consulting, technology, outsourcing, education and e-commerce. Ms. Meena Ganesh is the MD & CEO of Portea Medical, One of India’s largest and fastest growing home healthcare companies, which she co-founded in July 2013.
Ms. Meena Ganesh was appointed to the Board on March 8, 2019.
Composition of Committees of Board of Directors – Pfizer Limited